{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-019541","form_type":"8-K","ticker":"RNGE","cik":"0001438943","company_name":"RANGE IMPACT, INC.","filed_at":"2021-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.115370+00:00","generated_at":"2026-06-29T12:45:51.333518+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Vitality Biopharma shareholders elect directors and approve 2021 Stock Incentive Plan at annual meeting.","bullets":["Edward Feighan, Richard Celeste, Michael Cavanaugh elected as directors with >98% votes for.","2021 Stock Incentive Plan approved: 21,209,644 votes for, 638,306 against.","Advisory vote on executive compensation approved: 21,298,713 for, 523,948 against.","Stockholders preferred advisory votes on exec comp every 3 years (21,021,589 votes); board adopted that frequency.","Ratification of Meaden & Moore as auditor: 27,454,815 for, 101,379 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-019541","json":"https://secwatch.observer/filing/0001493152-21-019541.json","markdown":"https://secwatch.observer/filing/0001493152-21-019541.md","text":"https://secwatch.observer/filing/0001493152-21-019541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438943/000149315221019541/0001493152-21-019541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438943/000149315221019541/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T12:45:51.333518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}